Pulse Biosciences (PLSE) Change in Account Payables (2015 - 2025)
Pulse Biosciences' (PLSE) quarterly Change in Account Payables came in at -$186000.0 in Q4 2025, down 2557.14% year-on-year from $7569.8 in Q4 2024, and down 167.88% quarter-over-quarter from $274000.0 in Q3 2025.
Pulse Biosciences (PLSE) Change in Account Payables (2015 - 2025) Analysis & Trends
Pulse Biosciences' Change in Account Payables history runs 11 years deep, the most recent figure standing at -$186000.0 for Q4 2025.
- On a quarterly basis, Change in Account Payables fell 2557.14% year-over-year to -$186000.0 in Q4 2025; TTM through Dec 2025 was $1.1 million, a 663.18% increase from a year earlier, with the FY2025 full-year figure at $1.1 million, up 663.18% from the prior year.
- Change in Account Payables eased to -$186000.0 in Q4 2025 per PLSE's latest filing, from $274000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $712000.0 in Q1 2025 and bottomed at -$1.5 million in Q2 2022.
- The 5-year median for Change in Account Payables is $64000.0 (2022), against an average of $52500.0.
- Across the five-year window, Change in Account Payables jumped 6855.56% in 2021 and tumbled 2557.14% in 2025, its largest moves.
- Year by year, Change in Account Payables stood at $185000.0 in 2021, then sank by 321.08% to -$409000.0 in 2022, then jumped by 206.85% to $437000.0 in 2023, then slumped by 101.6% to -$7000.0 in 2024, then tumbled by 2557.14% to -$186000.0 in 2025.
- Per Business Quant, the three latest PLSE Change in Account Payables figures stand at -$186000.0 (Q4 2025), $274000.0 (Q3 2025), and $332000.0 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | - |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | -52.50 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | - |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 6.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | - |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | - |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | - |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -100.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 4.93 Mn |
| 10 | Pulse Biosciences | 2.09 Bn | 2.01 Bn | - | -186,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -186,000.00 |
| Dec 31, 2025 | -186,000.00 |
| Sep 30, 2025 | 274,000.00 |
| Sep 30, 2025 | 274,000.00 |
| Jun 30, 2025 | 332,000.00 |
| Jun 30, 2025 | 332,000.00 |
| Mar 31, 2025 | 712,000.00 |
| Mar 31, 2025 | 712,000.00 |
| Dec 31, 2024 | -7,000.00 |
| Dec 31, 2024 | -7,000.00 |
| Sep 30, 2024 | 92,000.00 |
| Sep 30, 2024 | 92,000.00 |
| Jun 30, 2024 | -162,000.00 |
| Jun 30, 2024 | -162,000.00 |
| Mar 31, 2024 | -124,000.00 |
| Mar 31, 2024 | -124,000.00 |
| Dec 31, 2023 | 437,000.00 |
| Dec 31, 2023 | 437,000.00 |
| Sep 30, 2023 | -386,000.00 |
| Sep 30, 2023 | -386,000.00 |